Ganoderenic acid D
Ganoderenic acid D is a triterpene identified from the effective compounds of Ganoderma lucidum extract (GLE) . Ganoderenic acid D inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis[1].
Product Specifications
CAS Number
100665-43-8
UNSPSC
12352211
Target
Apoptosis
Type
Natural Products
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ganoderenic-acid-d.html
Purity
99.51
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
C[C@]12C3=C(C(C[C@@]1([C@H](CC2=O)/C(C)=C/C(C[C@@H](C)C(O)=O)=O)C)=O)[C@@]4([C@@](C(C)(C(CC4)=O)C)([H])C[C@@H]3O)C
Molecular Formula
C30H40O7
Molecular Weight
512.63
References & Citations
[1]Zhao RL, et al. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice. J Ethnopharmacol. 2018 Jan 10;210:287-295.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740034-500 1x 500 µL
Cytokeratin 8/18 (C-51), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740198-500 1x 500 µL
Cytokeratin 18 (DA7), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details